Origin Materials (NASDAQ:ORGN) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Shares of Origin Materials, Inc. (NASDAQ:ORGN) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.64 and traded as low as $1.06. Origin Materials shares last traded at $1.12, with a volume of 80,976 shares.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ORGN shares. Weiss Ratings restated a “sell (e+)” rating on shares of Origin Materials in a research note on Friday, March 27th. Wall Street Zen upgraded shares of Origin Materials from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Origin Materials currently has an average rating of “Sell”.

Origin Materials Trading Up 2.8%

The stock has a market cap of $6.16 million, a P/E ratio of -0.02 and a beta of 1.12. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.66 and a quick ratio of 2.62. The business’s 50 day simple moving average is $1.68 and its 200 day simple moving average is $4.64.

Origin Materials (NASDAQ:ORGN) last announced its quarterly earnings results on Thursday, May 14th. The financial services provider reported ($3.28) EPS for the quarter, missing analysts’ consensus estimates of ($2.40) by ($0.88). The business had revenue of $0.48 million for the quarter, compared to the consensus estimate of $29.10 million. Origin Materials had a negative return on equity of 120.66% and a negative net margin of 1,742.04%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Jacobs Levy Equity Management Inc. raised its stake in shares of Origin Materials by 848.8% in the third quarter. Jacobs Levy Equity Management Inc. now owns 623,460 shares of the financial services provider’s stock valued at $323,000 after acquiring an additional 557,747 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Origin Materials by 4.1% in the third quarter. Vanguard Group Inc. now owns 5,552,860 shares of the financial services provider’s stock valued at $2,882,000 after acquiring an additional 220,421 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Origin Materials by 13.0% in the second quarter. Geode Capital Management LLC now owns 1,705,663 shares of the financial services provider’s stock valued at $824,000 after acquiring an additional 196,050 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Origin Materials by 756.3% in the fourth quarter. Renaissance Technologies LLC now owns 1,215,063 shares of the financial services provider’s stock valued at $257,000 after acquiring an additional 1,073,163 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its stake in shares of Origin Materials by 157.3% in the fourth quarter. Goldman Sachs Group Inc. now owns 279,903 shares of the financial services provider’s stock valued at $59,000 after acquiring an additional 171,105 shares during the last quarter. Institutional investors own 29.91% of the company’s stock.

About Origin Materials

Origin Materials, Inc is a cleantech company focused on producing sustainable chemicals and materials from renewable biomass rather than fossil feedstocks. The company’s core technology platform converts wood chips and other lignocellulosic feedstocks into a versatile intermediate called CMF (chloromethylfurfural), which can be further processed into a range of building‐block chemicals used in applications such as packaging, coatings and performance fibers. By offering a drop‐in alternative to petrochemical precursors, Origin Materials aims to reduce carbon emissions and environmental impact across multiple industries.

The company operates a demonstration facility in Sarnia, Ontario, where it validates its conversion process at scale and produces sample volumes of bio‐based intermediates.